1. |
Therrien J, Siu SC, Harris L, et al. Impact of pulmonary valve replacement on arrhythmia propensity late after repair of tetralogy of Fallot. Circulation, 2001, 103(20): 2489-2494.
|
2. |
Book WM, Kogon B, McConnell ME. Letter by Book et al regarding article, "pulmonary valve replacement in tetralogy of Fallot: impact on survival and ventricular tachycardia". Circulation, 2009, 120(10): e79;authorreplye80.
|
3. |
Mitchell MB. Pulmonary valve replacement for congenital heart disease: What valve substitute should we be using? J Thorac Cardiovasc Surg, 2016, 152(5): 1230-1232.
|
4. |
Yemets IM, Williams WG, Webb GD, et al. Pulmonary valve replacement late after repair of tetralogy of Fallot. Ann Thorac Surg, 1997, 64(2): 526-530.
|
5. |
Discigil B, Dearani JA, Puga FJ, et al. Late pulmonary valve replacement after repair of tetralogy of Fallot. J Thorac Cardiovasc Surg, 2001, 121(2): 344-351.
|
6. |
Warner KG, O'Brien PK, Rhodes J, et al. Expanding the indications for pulmonary valve replacement after repair of tetralogy of Fallot. Ann Thorac Surg, 2003, 76(4): 1066-1071.
|
7. |
Lim C, Lee JY, Kim WH, et al. Early replacement of pulmonary valve after repair of tetralogy: is it really beneficial? Eur J Cardiothorac Surg, 2004, 25(5): 728-734.
|
8. |
Cesnjevar R, Harig F, Raber A, et al. Late pulmonary valve replacement after correction of Fallot's tetralogy. Thorac Cardiovasc Surg, 2004, 52(1): 23-28.
|
9. |
Oosterhof T, Meijboom FJ, Vliegen HW, et al. Long-term follow-up of homograft function after pulmonary valve replacement in patients with tetralogy of Fallot. Eur Heart J, 2006, 27(12): 1478-1484.
|
10. |
Gengsakul A, Harris L, Bradley TJ, et al. The impact of pulmonary valve replacement after tetralogy of Fallot repair: a matched comparison. Eur J Cardiothorac Surg, 2007, 32(3): 462-468.
|
11. |
Oosterhof T, van Straten A, Vliegen HW, et al. Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation, 2007, 116(5): 545-551.
|
12. |
Graham TP Jr, Bernard Y, Arbogast P, et al. Outcome of pulmonary valve replacements in adults after tetralogy repair: a multi-institutional study. Congenit Heart Dis, 2008, 3(3): 162-167.
|
13. |
Scherptong RW, Hazekamp MG, Mulder BJ, et al. Follow-up after pulmonary valve replacement in adults with tetralogy of Fallot: association between QRS duration and outcome. J Am Coll Cardiol, 2010, 56(18): 1486-1492.
|
14. |
Shinkawa T, Anagnostopoulos PV, Johnson NC, et al. Performance of bovine pericardial valves in the pulmonary position. Ann Thorac Surg, 2010, 90(4): 1295-1300.
|
15. |
Lee C, Park CS, Lee CH, et al. Durability of bioprosthetic valves in the pulmonary position: long-term follow-up of 181 implants in patients with congenital heart disease. J Thorac Cardiovasc Surg, 2011, 142(2): 351-358.
|
16. |
Zubairi R, Malik S, Jaquiss RD, et al. Risk factors for prosthesis failure in pulmonary valve replacement. Ann Thorac Surg, 2011, 91(2): 561-565.
|
17. |
Lee C, Kim YM, Lee CH, et al. Outcomes of pulmonary valve replacement in 170 patients with chronic pulmonary regurgitation after relief of right ventricular outflow tract obstruction: implications for optimal timing of pulmonary valve replacement. J Am Coll Cardiol, 2012, 60(11): 1005-1014.
|
18. |
Jain A, Oster M, Kilgo P, et al. Risk factors associated with morbidity and mortality after pulmonary valve replacement in adult patients with previously corrected tetralogy of Fallot. Pediatr Cardiol, 2012, 33(4): 601-606.
|
19. |
Batlivala SP, Emani S, Mayer JE, et al. Pulmonary valve replacement function in adolescents: a comparison of bioprosthetic valves and homograft conduits. Ann Thorac Surg, 2012, 93(6): 2007-2016.
|
20. |
Chen PC, Sager MS, Zurakowski D, et al. Younger age and valve oversizing are predictors of structural valve deterioration after pulmonary valve replacement in patients with tetralogy of Fallot. J Thorac Cardiovasc Surg, 2012, 143(2): 352-360.
|
21. |
Jang W, Kim YJ, Choi K, et al. Mid-term results of bioprosthetic pulmonary valve replacement in pulmonary regurgitation after tetralogy of Fallot repair. Eur J Cardiothorac Surg, 2012, 42(1): e1-e8.
|
22. |
Chen XJ, Smith PB, Jaggers J, et al. Bioprosthetic pulmonary valve replacement: contemporary analysis of a large, single-center series of 170 cases. J Thorac Cardiovasc Surg, 2013, 146(6): 1461-1466.
|
23. |
McKenzie ED, Khan MS, Dietzman TW, et al. Surgical pulmonary valve replacement: a benchmark for outcomes comparisons. J Thorac Cardiovasc Surg, 2014, 148(4): 1450-1453.
|
24. |
Babu-Narayan SV, Diller GP, Gheta RR, et al. Clinical outcomes of surgical pulmonary valve replacement after repair of tetralogy of Fallot and potential prognostic value of preoperative cardiopulmonary exercise testing. Circulation, 2014, 129(1): 18-27.
|
25. |
Freling HG, van Slooten YJ, van Melle JP, et al. Pulmonary valve replacement: twenty-six years of experience with mechanical valvar prostheses. Ann Thorac Surg, 2015, 99(3): 905-910.
|
26. |
Nomoto R, Sleeper LA, Borisuk MJ, et al. Outcome and performance of bioprosthetic pulmonary valve replacement in patients with congenital heart disease. J Thorac Cardiovasc Surg, 2016, 152(5): 1333-1342.
|
27. |
Dobbels B, Herregods MC, Troost E, et al. Early versus late pulmonary valve replacement in patients with transannular patch-repaired tetralogy of Fallot. Interact Cardiovasc Thorac Surg, 2017, 25(3): 427-433.
|
28. |
Mitropoulos FM, Kanakis MA, Ntellos C, et al. Pulmonary valve replacement in patients with corrected tetralogy of Fallot. J Cardiovasc Thorac Res, 2017, 9(2): 71-77.
|
29. |
Li J, Luo S, Liu F, et al. Systolic function of right ventricular outflow tract is a better predictor to exercise performance after pulmonary valve replacement in tetralogy of Fallot. Pediatr Cardiol, 2017, 38(8): 1556-1561.
|
30. |
Egbe AC, Miranda WR, Said SM, et al. Risk stratification and clinical outcomes after surgical pulmonary valve replacement. Am Heart J, 2018, 206: 105-112.
|
31. |
Dipchand A, Cecere R, Delgado D, et al. Canadian Consensus on cardiac transplantation in pediatric and adult congenital heart disease patients 2004: executive summary. Can J Cardiol, 2005, 21(13): 1145-1147.
|
32. |
Taylor J. The 2010 version of the ESC guidelines for the management of grown-up adult congenital heart disease are discussed by guidelines task force chairman H. Baumgartner. Eur Heart J, 2010, 31(23): 2825-2826.
|
33. |
Ellison S, Lamb J, Haines A, et al. A guide for identification and continuing care of adult congenital heart disease patients in primary care. Int J Cardiol, 2013, 163(3): 260-265.
|
34. |
Bokma JP, Winter MM, Oosterhof T, et al. Preoperative thresholds for mid-to-late haemodynamic and clinical outcomes after pulmonary valve replacement in tetralogy of Fallot. Eur Heart J, 2016, 37(10): 829-835.
|
35. |
Bokma JP, Winter MM, Oosterhof T, et al. Pulmonary valve replacement after repair of pulmonary stenosis compared with tetralogy of Fallot. J Am Coll Cardiol, 2016, 67(9): 1123-1124.
|
36. |
龚启华, 杨一峰, 胡建国, 等. 成人法洛四联症的外科治疗. 中国胸心血管外科临床杂志, 2007, 14, (4): 303-305.
|
37. |
McRae ME, Coleman B, Atz TW, et al. Patient outcomes after transcatheter and surgical pulmonary valve replacement for pulmonary regurgitation in patients with repaired tetralogy of Fallot: A quasi-meta-analysis. Eur J Cardiovasc Nurs, 2017, 16(6): 539-553.
|
38. |
徐宏耀, 姬建胜, 王平凡, 等. 704 例法洛四联症矫治术的临床分析. 中国胸心血管外科临床杂志, 2016, 23(4): 408-410.
|